Divis Laboratories Ltd | DIVI - Ebitda

Preço das Ações
6,010.50
Mudança Diária
-3.00 -0.05%
Mensal
-6.02%
Anual
2.91%
Q1 Previsão
5,976.17




Ebitda Alterar Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurobindo Pharma INR 17.73B 952.4M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Lupin INR 23.09B 318.5M 2025-12
Moderna USD -790M 582M 2025-12
Organon & Co USD 383M 135M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12